Evaluating Impact and Implementation of Choose to Move (Phase 4) (CTM)

January 6, 2023 updated by: Heather McKay, University of British Columbia

Choose to Move (Phase 4): Impact and Implementation Evaluation of a Program to Enhance Older Adult Physical Activity, Mobility and Health

The objectives of this study are to: 1) evaluate whether Choose to Move (CTM) Phase 4 improves health outcomes in older adults who participate and 2) assess whether CTM Phase 4 is delivered as planned and what factors support or inhibit its delivery at scale.

CTM Phase 4 is a 3-month, choice-based program for low active older adults being scaled-up across British Columbia (BC), Canada. The goals of CTM are to enhance physical activity, mobility and social connectedness in older adults living in BC, Canada.

Study Overview

Detailed Description

Choose to Move (CTM) Phase 4 is a 3-month, choice-based program for low active older adults being scaled-up in phases across British Columbia (BC), Canada. Within CTM (Phase 4), trained activity coaches support older adults in two ways. First, in a one-on-one consultation, activity coaches help participants to set goals and create action plans for physical activity tailored to each person's interests and abilities. Older adults can choose to participate in individual or group-based activities. Second, activity coaches facilitate 8 group meetings with small groups of participants. Activity coaches and recreation departments across BC are trained and provided with resources to deliver CTM.

Objectives:

  1. To assess the impact (effectiveness) of CTM (Phase 4) delivered at scale on the physical activity, mobility, and social connectedness of older adults (Part I - Impact Evaluation)
  2. To assess whether CTM (Phase 4) was implemented as planned (fidelity) and investigate factors that support or inhibit its implementation at scale (Part II - Implementation Evaluation).

Study Design:

The investigators use a hybrid type 2 effectiveness-implementation (Curran et al 2012) pre-post study design to evaluate CTM. The investigators use multiple methods (quantitative and qualitative) and collect data at 0 (baseline), 3 (post-intervention), 6 (3 months post-intervention), 15 (12 months post-intervention) and 27 (24 months post-intervention) months to assess impact and implementation of CTM.

Study Type

Interventional

Enrollment (Anticipated)

1000

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • British Columbia
      • Vancouver, British Columbia, Canada, V5Z 1M9
        • Centre for Hip Health and Mobility, Robert H.N. Ho Research Centre, University of British Columbia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria (older adults):

  • ≥60 years of age
  • demonstrate readiness for physical activity via the PAR-Q+ questionnaire, Get Active Questionnaire, or a letter of recommendation from their physician
  • <150 min/week physical activity
  • English speaking
  • Able to connect to the Zoom or GoToMeeting platform via phone or internet in order to participate in virtual group meetings (for online programs only)

Exclusion Criteria (older adults):

  • Previous participation in CTM

Inclusion Criteria (delivery partners):

  • Activity coaches will be English speaking, British Columbia Recreation and Parks Association (BCRPA) registered older adult fitness leaders or kinesiologists who are delivering CTM at participating centres
  • Recreation Managers and Coordinators affiliated with participating centres delivering CTM
  • Provincial Partners (e.g., individuals/partners who make strategic and/or policy decisions) at partner organizations delivering Choose to Move

Activity Coach inclusion criteria:

  • Able to connect to the Zoom or GoToMeeting platform via internet (video and audio required in order to see and hear participants) for online programs
  • Able to connect to the Zoom or GoToMeeting platform via phone or internet in order to participate in virtual group meetings (for online programs only)
  • Currently (or recently completed) participating in CTM evaluation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Choose to Move

CTM (Phase 4) is a 3-month, flexible, choice-based program for low active older adults that can be delivered in-person or online.

CTM includes

  • One-on-One Consultation: Participants meet 1-on-1 with their activity coach at the start of the program to set goals and develop an action plan tailored to their abilities, interests and resources. Older adults can choose to participate in individual or group-based activities.
  • Group Meetings: Over the 3-months, participants will attend eight, 1-hour group-based meetings (up to 12 participants total) led by their activity coach. Meetings cover a discussion topic (health-related) and provide time and space for social connection between participants. Group meetings are held in person or online as public health restrictions and community preference dictate.
As described under study arm description.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in physical activity
Time Frame: 0, 3, 6, 15, 27-months
The single item physical activity questionnaire will be used to measure physical activity. Output variable is self-reported number of days/week ≥30 min physical activity in the past week (range 0-7).
0, 3, 6, 15, 27-months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in capacity for mobility
Time Frame: 0, 3, 6, 15, 27-months
Two items will assess participants' ability to walk a quarter of a mile and up 10 steps. The output variable is self-reported presence of mobility-disability (no/any difficulty walking 400m or climbing one flight of stairs).
0, 3, 6, 15, 27-months
Change in physical functioning
Time Frame: 0, 3, 6, 15, 27-months
The Physical Functioning Subscale of the SF-36 will be used to assess the physical function aspect of mobility. The measure asks participants to rate if their health limits them in performing 10 different activities. The output variable is an average score (range 0-100) of physical functioning, where a higher score indicates a more favourable health state.
0, 3, 6, 15, 27-months
Change in mobility
Time Frame: 0, 3, 6, 15, 27-months
The Mobility Assessment Tool-Short Form (MAT-sf) will be used to assess mobility. MAT-sf is a validated, short form video-animated tool to assess participant self-perception of mobility. Only participants with an internet connection are able to complete this measure. The output variable is a self-perception of mobility score (range 23.45-67.61) where a higher score indicates greater perceived mobility.
0, 3, 6, 15, 27-months
Change in loneliness
Time Frame: 0, 3, 6, 15, 27-months
The three-item loneliness scale will be used to assess loneliness. Participants rate three aspects of loneliness. The output variable is loneliness score (range 3-9); lower scores indicate lower levels of loneliness.
0, 3, 6, 15, 27-months
Change in social isolation
Time Frame: 0, 3, 6, 15, 27-months
A three-item questionnaire adapted from two questions on social contact frequency will be used to assess social isolation. The output variable is social isolation score (range 0-15); higher scores indicate lower levels of social isolation.
0, 3, 6, 15, 27-months
Change in social network
Time Frame: 0, 3, 6, 15, 27-months
A six-item questionnaire will be used to assess social network. The output variable is an equally weighted sum (range 0-30) where higher scores indicate more social engagement.
0, 3, 6, 15, 27-months
Change in social connectedness
Time Frame: 0, 3, 6, 15, 27-months
A single item will be used to assess sense of belonging as an indicator of social connectedness. The output variable is sense of belonging score (range 1-4) where lower scores indicate a stronger sense of belonging.
0, 3, 6, 15, 27-months
Change in sitting time
Time Frame: 0, 3, 6, 15, 27-months
A five-item questionnaire will be used to assess change in sitting time (hours and minutes) each day in the following domains: (a) while travelling to and from places (e.g., work, shops); (b) while at work; (c) while watching television; (d) while using a computer at home; and (e) at leisure not including watching television (e.g., visiting friends, movies, eating out) on a weekday and a weekend day. The output variables are sitting hours per day across 5 domains.
0, 3, 6, 15, 27-months
Change in screen time
Time Frame: 0, 3, 6, 15, 27-months
A single item will be used to assess screen time. The output variable is hours of screen time per day.
0, 3, 6, 15, 27-months
Change in health-related quality of life (EQ-5D-5L Profile)
Time Frame: 0, 3, 6, 15, 27-months
Health status will be assessed using the EQ-5D-5L. Participants report on mobility, self-care, usual activities, pain/discomfort and anxiety/depression on a scale from 1-5 (level of perceived problems) for each item. Responses are used to create a 5-digit number which will be used descriptively (11111 indicates no problems on any of the five dimensions whereas 55555 indicates extreme problems on all five dimensions).
0, 3, 6, 15, 27-months
Change in health-related quality of life (EQ-5D-5L Level Sum Score)
Time Frame: 0, 3, 6, 15, 27-months
Health status (EQ-5D-5L Level Sum Score) will be assessed with the EQ-5D-5L. Participants report on mobility, self-care, usual activities, pain/discomfort and anxiety/depression on a scale from 1-5 (level of perceived problems) for each item. The Level Sum Score uses the 5-digit profile to create a numeric score, with scores ranging from 5-25 (lower levels indicate lower levels of perceived problems).
0, 3, 6, 15, 27-months
Change in health-related quality of life (EQ-5D-5L Visual Analogue Scale)
Time Frame: 0, 3, 6, 15, 27-months
Health status will be assessed with the EQ-5D-5L visual analogue scale. Participants report on their health on a visual analogue scale from 0 (worst health) to 100 (best health).
0, 3, 6, 15, 27-months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reach-individual
Time Frame: 3-months
The number of participants engaged in the intervention will be obtained from program records.
3-months
Reach-organizational
Time Frame: 3-months
The number of organizations and activity coaches delivering the intervention will be obtained from program records.
3-months
Dose delivered
Time Frame: 3-months
The amount of intervention delivered will be assessed via survey (designed in house). Lower scores indicate that a lower dose of the intervention was delivered than planned.
3-months
Fidelity (survey)
Time Frame: 3-months
Fidelity to planned delivery will be assessed via survey (designed in house). Higher scores indicate better adherence to planned delivery.
3-months
Fidelity (interview/focus group)
Time Frame: 3-months
Fidelity to planned delivery will be assessed via interview/focus group.
3-months
Participant responsiveness (survey)
Time Frame: 3-months
Program satisfaction will be assessed via participant survey (designed in house). Higher scores indicate higher participant satisfaction with the intervention.
3-months
Participant responsiveness (interview)
Time Frame: 3-months
Program satisfaction will be assessed via interview.
3-months
Adaptation (survey)
Time Frame: 3-months
Adaptation of the intervention and its delivery will be assessed via survey (designed in house).
3-months
Adaptation (interview/focus group)
Time Frame: 3-months
Adaptation of the intervention and its delivery will be assessed via interview/focus groups.
3-months
Contextual factors influencing implementation (survey)
Time Frame: 3-months
Contextual factors influencing implementation (community level factors, provider characteristics, characteristics of the innovation, the prevention delivery system, organizational capacity and the prevention support system) will be assessed via survey (designed in house).
3-months
Contextual factors influencing implementation (interview/focus group)
Time Frame: 3-months
Contextual factors influencing implementation (community level factors, provider characteristics, characteristics of the innovation, the prevention delivery system, organizational capacity and the prevention support system) will be assessed via interviews/focus groups.
3-months
Cost
Time Frame: 3-months
Program delivery costs will be recorded using a cost capture template.
3-months
Change in Organizational Readiness (Organizational Readiness Rubric)
Time Frame: 0, 3-months
Organizational readiness (OR) will be assessed via survey (Organizational Readiness Rubric; ORR). The ORR comprises 14 items, each scored from 1-5. Higher mean scores indicate greater organizational readiness.
0, 3-months
Change in Organizational Readiness (Readiness for Organizational Change Scale)
Time Frame: 0, 3-months
Organizational readiness (OR) will be assessed via survey (Readiness for Organizational Change Scale; ROCS). ROCS includes 25 items, each scored on a 5-point scale (1= strongly disagree to 5=strongly agree). Higher mean scores indicate greater organizational readiness for change.
0, 3-months
Organizational Readiness (OR) (interview/focus group)
Time Frame: 0, 3-months
Organizational readiness (OR) will be assessed via interview.
0, 3-months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Heather A McKay, PhD, University of British Columbia
  • Principal Investigator: Joanie Sims Gould, PhD, University of British Columbia

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 17, 2020

Primary Completion (Anticipated)

January 1, 2025

Study Completion (Anticipated)

January 1, 2025

Study Registration Dates

First Submitted

December 19, 2022

First Submitted That Met QC Criteria

January 6, 2023

First Posted (Estimate)

January 10, 2023

Study Record Updates

Last Update Posted (Estimate)

January 10, 2023

Last Update Submitted That Met QC Criteria

January 6, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • H20-00780 (Other Identifier: University of British Columbia)
  • PJT-169159 (Other Grant/Funding Number: Canadian Institutes of Health Research)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aging

Clinical Trials on Choose to Move

3
Subscribe